FN1 emerged as a particularly intriguing mediator, as it is upregulated in both sporadic and genetic forms of cSVD36–38, yet rare loss-of-function variants in FN1 protect against Alzheimer’s disease in APOE4 homozygotes38,39. This evidence concerns the gene APOE and early-onset autosomal dominant Alzheimer disease.